Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy.
Aged
Aged, 80 and over
Atrial Fibrillation
Betacoronavirus
COVID-19
Coronavirus Infections
/ complications
Creatinine
/ blood
Female
Heart Diseases
/ complications
Heart Failure
Hospitalization
Humans
Italy
/ epidemiology
Male
Middle Aged
Natriuretic Peptide, Brain
/ blood
Pandemics
Peptide Fragments
/ blood
Pneumonia, Viral
/ complications
Prognosis
Respiratory Distress Syndrome
Risk Factors
SARS-CoV-2
Shock, Septic
Thromboembolism
Troponin T
/ blood
COVID-19
Cardiovascular disease
Mortality
Pneumonia
Journal
European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263
Informations de publication
Date de publication:
14 05 2020
14 05 2020
Historique:
received:
01
04
2020
revised:
17
04
2020
accepted:
06
05
2020
pubmed:
10
5
2020
medline:
20
5
2020
entrez:
9
5
2020
Statut:
ppublish
Résumé
To compare demographic characteristics, clinical presentation, and outcomes of patients with and without concomitant cardiac disease, hospitalized for COVID-19 in Brescia, Lombardy, Italy. The study population includes 99 consecutive patients with COVID-19 pneumonia admitted to our hospital between 4 March and 25 March 2020. Fifty-three patients with a history of cardiac disease were compared with 46 without cardiac disease. Among cardiac patients, 40% had a history of heart failure, 36% had atrial fibrillation, and 30% had coronary artery disease. Mean age was 67 ± 12 years, and 80 (81%) patients were males. No differences were found between cardiac and non-cardiac patients except for higher values of serum creatinine, N-terminal probrain natriuretic peptide, and high sensitivity troponin T in cardiac patients. During hospitalization, 26% patients died, 15% developed thrombo-embolic events, 19% had acute respiratory distress syndrome, and 6% had septic shock. Mortality was higher in patients with cardiac disease compared with the others (36% vs. 15%, log-rank P = 0.019; relative risk 2.35; 95% confidence interval 1.08-5.09). The rate of thrombo-embolic events and septic shock during the hospitalization was also higher in cardiac patients (23% vs. 6% and 11% vs. 0%, respectively). Hospitalized patients with concomitant cardiac disease and COVID-19 have an extremely poor prognosis compared with subjects without a history of cardiac disease, with higher mortality, thrombo-embolic events, and septic shock rates.
Identifiants
pubmed: 32383763
pii: 5834516
doi: 10.1093/eurheartj/ehaa388
pmc: PMC7239204
doi:
Substances chimiques
Peptide Fragments
0
Troponin T
0
pro-brain natriuretic peptide (1-76)
0
Natriuretic Peptide, Brain
114471-18-0
Creatinine
AYI8EX34EU
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1821-1829Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : ErratumIn
Type : CommentIn
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Références
JACC Heart Fail. 2016 Jul;4(7):591-599
pubmed: 27039129
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA Intern Med. 2020 Mar 13;:
pubmed: 32167524
Eur Heart J. 2020 Mar 16;:
pubmed: 32176778
Hypertension. 2020 Jun;75(6):1382-1385
pubmed: 32208987
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219363
Eur J Heart Fail. 2019 Jun;21(6):715-731
pubmed: 31222929
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
JAMA Cardiol. 2020 Mar 25;:
pubmed: 32211816
N Engl J Med. 2020 May 21;382(21):2012-2022
pubmed: 32227758
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
JAMA. 2020 Mar 13;:
pubmed: 32167538
JAMA Cardiol. 2020 Mar 27;:
pubmed: 32219356
Eur Heart J. 2018 Oct 14;39(39):3615-3617
pubmed: 28525640
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Crit Care. 2019 Nov 27;23(1):374
pubmed: 31775846
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Eur J Heart Fail. 2019 Aug;21(8):965-973
pubmed: 31087601
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2020 Mar 19;:
pubmed: 32191259
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Eur Heart J. 2020 Feb 01;:
pubmed: 32006431
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
JAMA. 2016 Feb 23;315(8):762-74
pubmed: 26903335
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632